Daiichi Sankyo Europe pursues a strategy of sustainable growth. As part of our strategy, we employ an operating model that systematically places the interests of our stakeholders, customers and patients at the centre of our activities.
By doing this we fulfil their need for innovative medications, healthcare solutions and information about our products and therapeutic areas. Using a customer-centric operating model, we are able to successfully respond to the constant, ever-more rapid changes in the healthcare environment, to face new challenges and to appeal to new interest groups entering the marketplace.
In the process, we draw on the passionate commitment of our employees, their expertise and their desire to expand their personal knowledge base, as well as on our products being sold in the marketplace and our outstanding product pipeline. At the same time, we continuously search for promising partnerships with other companies, in-licensing opportunities and acquisitions.
As a research-based pharmaceutical company, we focus on providing solutions to address unmet medical…
You are now leaving our website. Please note that our terms of use (especially those mentioned under "Disclaimer" and "Imprint") are no longer valid as soon as you click on the "Continue" button. As we do not have any influence on linked websites, we assume no liability for their content. If you would like to return to our website, please click the "Return" button.
